Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

N(1)-methyl-2-lysergic acid diethylamide

Known as: MIL 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Lysergic Acid Diethylamide
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MIL-PVDF blend ultrafiltration membranes with ultrahigh MOF loading for simultaneous adsorption and catalytic oxidation of methylene blue.
Multifunctional ultrafiltration membranes need to be further developed with ultrafiltration performance and high multifunctional… Expand
Is this relevant?
2019
2019
Effects of intravenous phosphodiesterase inhibitors and corticosteroids on severe meconium aspiration syndrome.
BACKGROUND Meconium aspiration syndrome (MAS) is a major cause of severe respiratory failure in near- and full-term neonates… Expand
Is this relevant?
2019
2019
Impact of Anesthetics on Cardioprotection Induced by Pharmacological Preconditioning
Anesthetics, especially propofol, are discussed to influence ischemic preconditioning. We investigated whether cardioprotection… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2015
2015
Результаты пРименения манитно-инфРакРасной лазеРной теРапии в комплексном лечении больных с впеРвые выявленным дестРуктивным тубеРкулезом легких
Aim. To compare the effectiveness of treatment of destructive, bacillary pulmonary tuberculosis in new- onset patients treated… Expand
Is this relevant?
2004
2004
Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133
Octadecyl-[2-(N-methylpiperidinio)ethyl]-phosphate (OMPEP, D-20133), a heterocyclic analogue of hexadecylphosphocholine (MIL… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Functional Cloning of the Miltefosine Transporter
The antitumor drug miltefosine (hexadecylphosphocholine, MIL) has recently been approved as the first oral agent for the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Comparison of the cardiovascular effects of intracellular cyclic adenosine 3',5'-monophosphate (cAMP)-modulating agents in isoflurane-anesthetized cats.
The inotropic, chronotropic, and vasodilatory effects of five commonly used cyclic adenosine 3',5'-monophosphate (cAMP… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1994
1994
Chemical capture of free-ranging red deer (Cervus elaphus) with medetomidine-ketamine
Seventeen free-ranging red deer (Cervus elaphus) (12 calves and 5 yearling hinds) were immobilized with a combination of… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
1993
1993
Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
Milrinone (MIL; a cAMP-specific phosphodiesterase type-III inhibitor), added in vitro to achieve concentrations below the… Expand
Is this relevant?
1987
1987
Acute and subacute hemodynamic effects of enalaprilat, milrinone and combination therapy in rats with chronic left ventricular dysfunction.
A model of congestive heart failure (CHF) was produced in rats approximately 76 days following surgical occlusion of the left… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE